Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sinovac Biotech Ltd.

    NASDAQ: SVA · Real-Time Price · USD
    6.47
    0.00 (0.00%)
    At close: Feb 11, 2025, 6:18 AM

    Sinovac Biotech Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2024 Q3 2023 Q1 2023 Q3 2022 Q1 2022 Q3 2021 Q1 2021
    Period Ending Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
    Revenue
    		 728.74M 1.63B 9.89B 20.59B 19.82B 11.48B 510.62M
    Cost of Revenue
    		 618.5M 872.87M 1.12B 1.33B 1.13B 696.97M 67.18M
    Gross Profit
    		 110.24M 760.3M 8.76B 19.26B 18.69B 10.78B 443.44M
    Operating Income
    		 -1.63B -892.18M 6.96B 18.17B 17.78B 10.36B 215.64M
    Interest Income
    		 191.93M 220.41M 262.58M 186.57M 103.35M 32.23M 1.93M
    Pretax Income
    		 -1.05B -38.37M 7.43B 18.49B 17.79B 10.39B 216.62M
    Net Income
    		 -470.56M 130.78M 3.47B 8.95B 8.59B 5.22B 110.37M
    Selling & General & Admin
    		 1.08B 1.06B 1.26B 750.82M 724.41M 322.17M 176.53M
    Research & Development
    		 602.23M 593.24M 543.24M 339.43M 183.65M 96.98M 48.76M
    Other Expenses
    		 n/a n/a n/a n/a 1.37M 1.2M 1.29M
    Operating Expenses
    		 1.68B 1.65B 1.8B 1.09B 909.63M 421.41M 227.64M
    Interest Expense
    		 2.9M 1.53M 2.58M 3.46M 3.69M 2.75M 1.45M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 2.36B 2.53B 2.93B 2.42B 2.04B 1.12B 294.82M
    Income Tax Expense
    		 -93.53M -96.49M 1.47B 3.24B 3.14B 1.6B 31.44M
    Shares Outstanding (Basic)
    		 99.6M 99.58M 99.5M 99.5M 99.34M 99.29M 98.9M
    Shares Outstanding (Diluted)
    		 99.6M 114.23M 99.5M 114.17M 114M 114.01M 113.66M
    EPS (Basic)
    		 -4.73 1.31 34.96 90.14 86.46 52.60 1.09
    EPS (Diluted)
    		 -4.75 0.66 29.98 78.51 75.33 45.82 0.96
    EBITDA
    		 -1.41B -651.44M 7.18B 18.33B 17.87B 10.38B 221.76M
    EBIT
    		 -1.05B -36.84M 7.43B 18.49B 17.79B 10.39B 218.07M
    Depreciation & Amortization
    		 140.05M 370.49M 281.64M 575.89M 287.94M 294.25M 5.52M

    Add to Watchlist